Even the entrepreneurial and investment ecosystem has not been spared by the coronavirus. In our first exclusive global o2h ChaiTime webinar we quizzed our panelists on the future landscape for early stage investing in a post COVID-19 pandemic environment.
In the panel we had President and CEO of one of the largest healthcare technology companies, a seasoned start-up entrepreneur, an early stage Angel investor, a fund manager, a wealth manager and a start-up entrepreneur who has been featured for his AI platform that could lead to new therapeutic combinations against COVID-19.
Kieran is a president and CEO of GE Healthcare, a leading global medical technology company employing 50,000 people around the globe.
Peyman is CEO of AIVIVO, an AI platform to support discovery therapeutics.
Goncalo is CEO of RNWL and Founder of Syndicate Room.
Sanjeev is a Commercial Director of Newable, Technology EIS Fund.
Steve Thurlby is a Wealth Management Advisor at Fairstone Group.
Deepali is an angel investor and advisor to female founders.
A serial entrepreneur having begun a career in the Life Sciences team at PA Consulting group followed by co-founding two companies in the information technology and life sciences sector.